Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
Evidence has shown that women with a history of preeclampsia or haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome have an increased risk of cardiovascular disease later in life. Recommendations for screening, prevention and management after such pregnancies are not yet defined. T...
Enregistré dans:
Auteurs principaux: | Esmee ME Bovee, Martha Gulati, Angela HEM Maas |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c1f3a2bf47534202b416901e418169ec |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
par: Pensée Wu, et autres
Publié: (2021) -
Trending cardiac biomarkers during pregnancy in women with cardiovascular disease
par: Soohyun Chang, et autres
Publié: (2021) -
Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
par: Mattia Cattaneo, et autres
Publié: (2019) -
The Coronavirus Disease 2019 Outbreak Highlights the Importance of Sex-sensitive Medicine
par: Angela HEM Maas, et autres
Publié: (2020) -
Advanced Cardiac Interventions During Pregnancy: A Personal Perspective
par: Angela HEM Maas
Publié: (2021)